Literature DB >> 24275656

Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.

Greg A Snyder1, Daniel Deredge, Anna Waldhuber, Theresa Fresquez, David Z Wilkins, Patrick T Smith, Susi Durr, Christine Cirl, Jiansheng Jiang, William Jennings, Timothy Luchetti, Nathaniel Snyder, Eric J Sundberg, Patrick Wintrode, Thomas Miethke, T Sam Xiao.   

Abstract

The Toll/IL-1 receptor (TIR) domains are crucial innate immune signaling modules. Microbial TIR domain-containing proteins inhibit Toll-like receptor (TLR) signaling through molecular mimicry. The TIR domain-containing protein TcpB from Brucella inhibits TLR signaling through interaction with host adaptor proteins TIRAP/Mal and MyD88. To characterize the microbial mimicry of host proteins, we have determined the X-ray crystal structures of the TIR domains from the Brucella protein TcpB and the host adaptor protein TIRAP. We have further characterized homotypic interactions of TcpB using hydrogen/deuterium exchange mass spectrometry and heterotypic TcpB and TIRAP interaction by co-immunoprecipitation and NF-κB reporter assays. The crystal structure of the TcpB TIR domain reveals the microtubule-binding site encompassing the BB loop as well as a symmetrical dimer mediated by the DD and EE loops. This dimerization interface is validated by peptide mapping through hydrogen/deuterium exchange mass spectrometry. The human TIRAP TIR domain crystal structure reveals a unique N-terminal TIR domain fold containing a disulfide bond formed by Cys(89) and Cys(134). A comparison between the TcpB and TIRAP crystal structures reveals substantial conformational differences in the region that encompasses the BB loop. These findings underscore the similarities and differences in the molecular features found in the microbial and host TIR domains, which suggests mechanisms of bacterial mimicry of host signaling adaptor proteins, such as TIRAP.

Entities:  

Keywords:  Bacterial Pathogenesis; Crystal Structure; Innate Immunity; Mal TIRAP; Signal Transduction; TcpB; Toll IL-1 Receptor (TIR) Domain

Mesh:

Substances:

Year:  2013        PMID: 24275656      PMCID: PMC3887195          DOI: 10.1074/jbc.M113.523407

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.

Authors:  Xiao Tao; Yingwu Xu; Ye Zheng; Amer A Beg; Liang Tong
Journal:  Biochem Biophys Res Commun       Date:  2002-11-29       Impact factor: 3.575

2.  Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling.

Authors:  Jonathan C Kagan; Ruslan Medzhitov
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

3.  Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.

Authors:  Zhengfan Jiang; Philippe Georgel; Chenglong Li; Jungwoo Choe; Karine Crozat; Sophie Rutschmann; Xin Du; Tim Bigby; Suzanne Mudd; Sosathya Sovath; Ian A Wilson; Arthur Olson; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 4.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

5.  Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins.

Authors:  Ruchi M Newman; Prabhakar Salunkhe; Adam Godzik; John C Reed
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.

Authors:  Maria Loiarro; Claudio Sette; Grazia Gallo; Andrea Ciacci; Nicola Fantò; Domenico Mastroianni; Paolo Carminati; Vito Ruggiero
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

8.  Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank.

Authors:  Huanwang Yang; Vladimir Guranovic; Shuchismita Dutta; Zukang Feng; Helen M Berman; John D Westbrook
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-09-23

9.  Characterization of a TIR-like protein from Paracoccus denitrificans.

Authors:  Lieh Yoon Low; Takashi Mukasa; John C Reed; Jaime Pascual
Journal:  Biochem Biophys Res Commun       Date:  2007-03-07       Impact factor: 3.575

10.  Developments in the CCP4 molecular-graphics project.

Authors:  Liz Potterton; Stuart McNicholas; Eugene Krissinel; Jan Gruber; Kevin Cowtan; Paul Emsley; Garib N Murshudov; Serge Cohen; Anastassis Perrakis; Martin Noble
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26
View more
  37 in total

1.  Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling.

Authors:  Mark M Hughes; Peter Lavrencic; Rebecca C Coll; Thomas Ve; Dylan G Ryan; Niamh C Williams; Deepthi Menon; Ashley Mansell; Philip G Board; Mehdi Mobli; Bostjan Kobe; Luke A J O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

2.  A non-uniform sampling approach enables studies of dilute and unstable proteins.

Authors:  Tomas Miljenović; Xinying Jia; Peter Lavrencic; Bostjan Kobe; Mehdi Mobli
Journal:  J Biomol NMR       Date:  2017-02-10       Impact factor: 2.835

Review 3.  Assembly and localization of Toll-like receptor signalling complexes.

Authors:  Nicholas J Gay; Martyn F Symmons; Monique Gangloff; Clare E Bryant
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

4.  Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling.

Authors:  Thomas Ve; Parimala R Vajjhala; Andrew Hedger; Tristan Croll; Frank DiMaio; Shane Horsefield; Xiong Yu; Peter Lavrencic; Zahid Hassan; Garry P Morgan; Ashley Mansell; Mehdi Mobli; Ailis O'Carroll; Brieuc Chauvin; Yann Gambin; Emma Sierecki; Michael J Landsberg; Katryn J Stacey; Edward H Egelman; Bostjan Kobe
Journal:  Nat Struct Mol Biol       Date:  2017-07-31       Impact factor: 15.369

Review 5.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 6.  Bacteria, the endoplasmic reticulum and the unfolded protein response: friends or foes?

Authors:  Jean Celli; Renée M Tsolis
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

7.  Blocking TIR Domain Interactions in TLR9 Signaling.

Authors:  Artur Javmen; Henryk Szmacinski; Joseph R Lakowicz; Vladimir Y Toshchakov
Journal:  J Immunol       Date:  2018-06-18       Impact factor: 5.422

8.  Immune responses of bison and efficacy after booster vaccination with Brucella abortus strain RB51.

Authors:  S C Olsen; J L McGill; R E Sacco; S G Hennager
Journal:  Clin Vaccine Immunol       Date:  2015-02-11

9.  SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.

Authors:  Daniel W Summers; Daniel A Gibson; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

10.  Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation.

Authors:  Anna Waldhuber; Manoj Puthia; Andreas Wieser; Christine Cirl; Susanne Dürr; Silke Neumann-Pfeifer; Simone Albrecht; Franziska Römmler; Tina Müller; Yunji Zheng; Sören Schubert; Olaf Groß; Catharina Svanborg; Thomas Miethke
Journal:  J Clin Invest       Date:  2016-05-23       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.